Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Jezik
Vsa polja
Naslov
Avtor
Tema
Signatura
ISBN/ISSN
Oznaka
Išči
Napredno
Treatment of Metastatic Medull...
Citiraj
Pošljite SMS
Pošljite email
Natisni
Izvozi zadetek
Izvozi v RefWorks
Izvozi v EndNoteWeb
Izvozi v EndNote
Permanent link
Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply
Bibliografske podrobnosti
Main Authors:
Jr, W
,
Robinson, BG
,
Gagel, R
,
Dralle, H
,
Fagin, J
,
Santoro, M
,
Baudin, E
,
Elisei, R
,
Jarzab, B
,
Vasselli, JR
,
Read, J
,
Langmuir, P
,
Ryan, A
,
Schlumberger, M
Format:
Journal article
Izdano:
2012
Zaloga
Opis
Podobne knjige/članki
Knjižničarski pogled
Podobne knjige/članki
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
od: Wells, SA, et al.
Izdano: (2012)
Reply to J.-F. Chatal et al.
od: Wells Jr, SA, et al.
Izdano: (2012)
Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
od: Nils Degrauwe, et al.
Izdano: (2012-06-01)
Calcitonin receptor expression in medullary thyroid carcinoma
od: Virginia Cappagli, et al.
Izdano: (2017-09-01)
Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer
od: Ecem Bostan, et al.
Izdano: (2022-09-01)